Results
1 -
10 of
51Jiménez C., Ventura R., Segura J..
Detection in urine of efaproxiral (RSR13), a potential doping agent, by a routine screening procedure based on methylation followed by gas chromatography/mass spectrometry, Analytica Chimica Acta, 2004 Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo, Cancer Chemotherapy and Pharmacology Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors, Radiation Oncology The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics, Journal of Neuro-Oncology Banned and Approved Substances, Essential Sports Medicine The Dose-Dependent Effect of RSR13, a Synthetic Allosteric Modifier of Hemoglobin, on Physiological Parameters and Brain Tissue Oxygenation in Rats, Oxygen Transport to Tissue XXIV Allosteric Modification of Hemoglobin by RSR13 as a Therapeutic Strategy, Oxygen Transport to Tissue XXIV The Effect of RSR13, a Synthetic Allosteric Modifier of Hemoglobin, on Brain Tissue pO2 (Measured by Eproximetry) Following Severe Hemorrhagic Shock in Rats, Oxygen Transport to Tissue XXIV Modeling of the Response of ptO2 in Rat Brain to Changes in Physiological Parameters, Oxygen Transport to Tissue XXVI Effect of RSR13 on Temperature-Dependent Changes in Hemoglobin Oxygen Affinity of Human Whole Blood, Oxygen Transport to Tissue XX